Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Actinium Pharmaceuticals, Inc. (ATNM) had Current Ratio of 7.96 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.09M |
|
$-5.13M |
|
-- |
|
$0.09M |
|
$5.78M |
|
$-5.69M |
|
$0.56M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.13M |
|
$-5.69M |
|
$-5.49M |
|
31.20M |
|
31.20M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$54.37M |
|
$0.23M |
|
$1.78M |
|
$56.15M |
|
$6.83M |
|
$0.00M |
|
$35.53M |
|
$42.37M |
|
$13.78M |
|
$13.78M |
|
$13.78M |
|
31.20M |
|
| Cash Flow Statement Financials | |
$-19.29M |
|
-- |
|
$-0.21M |
|
$73.23M |
|
$53.72M |
|
$-19.50M |
|
$9.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
7.96 |
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-6324.44% |
|
-6324.44% |
|
-- |
|
-5701.11% |
|
-5701.11% |
|
$-19.29M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-37.22% |
|
-37.22% |
|
-9.14% |
|
-37.22% |
|
$0.44 |
|
$-0.62 |
|
$-0.62 |
|